Central Laboratory Services

Central Laboratory Services from Zuri Therapeutic Services, Inc in Laurel, MD are built to keep your multi-site trials scientifically aligned, inspection-ready, and on schedule. We coordinate every laboratory activity under a single operational framework so sponsors see consistent methods, consistent data, and fewer surprises at database lock.

Our central lab management team oversees day-to-day operations, from test menu design and kit configuration to data transfer schedules and query resolution. For biomarker analysis, we design and execute panels that clearly track drug exposure, pharmacodynamic effects, and patient response, giving your clinicians and statisticians data they can act on early. Bioanalytical testing is performed with validated methods that accurately quantify parent compounds and metabolites in complex matrices, supporting dose selection, exposure-response modeling, and regulatory submissions. In parallel, our genomic assays provide high-quality DNA and RNA readouts for precision medicine programs, including variant detection, expression profiling, and exploratory biomarker discovery.

We also support immunoassay development when standard kits do not fit your program. Our scientists design, optimize, and validate assays to detect proteins, antibodies, or other analytes at relevant ranges, then integrate those methods into routine sample testing with clear documentation for regulators.

Sample processing and storage are tightly controlled from collection through long-term retention. We manage chain of custody, centrifugation, aliquoting, and labelling, followed by temperature-monitored storage with predefined retrieval procedures. This protects sample integrity, reduces re-draws, and maintains compliance with protocol and GCP expectations.

All data streams-from central safety labs, bioanalytical platforms, and biomarker or genomic workflows-are reconciled and formatted to align with your data management plan. The outcome is a single, coherent laboratory backbone that shortens timelines, reduces rework, and gives sponsors clear visibility into laboratory performance across every site in the trial.